Birzeit Pharmaceuticals Company (PEX:BPC)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
3.790
+0.040 (1.07%)
At close: May 7, 2026
Market Cap104.11M -7.3%
Revenue (ttm)34.00M +18.0%
Net Income8.47M +130.5%
EPS0.22 +130.5%
Shares Out38.76M
PE Ratio12.28
Forward PEn/a
Dividend0.04 (1.32%)
Ex-Dividend DateMay 6, 2026
Volume235
Average Volume5,479
Open3.790
Previous Close3.750
Day's Range3.790 - 3.790
52-Week Range3.550 - 4.450
Beta-0.11
RSI39.30
Earnings DateMay 14, 2026

About PEX:BPC

Birzeit Pharmaceuticals Company operates as a pharmaceutical manufacturing company in the Palestinian Authority. The company offers OTC products for alimentary system cardiovascular system, central nervous system, musculo-skeletal system, endocrine, genito-urinary system, diabetes, obstetrics and gynecology infections, affecting nutrition and metabolism, respiratory system, ophthalmic drugs, dermatological preparations, and dietary supplements, as well as ear, nose, and oropharynx therapeutic areas. It serves the Ministry of Health, healthcare ... [Read more]

Industry Pharmaceutical Preparations
Founded 1973
Employees 372
Stock Exchange Palestine Stock Exchange
Ticker Symbol BPC
Full Company Profile

Financial Performance

In 2025, PEX:BPC's revenue was $47.96 million, an increase of 17.98% compared to the previous year's $40.65 million. Earnings were $11.95 million, an increase of 130.54%.

Financial numbers in USD Financial Statements